BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 17411005)

  • 1. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
    Novak E; Allen PJ
    Pediatr Nurs; 2007; 33(1):64-70. PubMed ID: 17411005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.
    Pediatrics; 1996 Jul; 98(1):143-5. PubMed ID: 8668390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uses of drugs not described in the package insert (off-label uses).
    Committee on Drugs. American Academy of Pediatrics
    Pediatrics; 2002 Jul; 110(1 Pt 1):181-3. PubMed ID: 12093968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing for children: issues in pediatric pharmacology.
    Niederhauser VP
    Nurse Pract; 1997 Mar; 22(3):16-8, 23, 26-8 passim. PubMed ID: 9078512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey.
    Chen DT; Wynia MK; Moloney RM; Alexander GC
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1094-100. PubMed ID: 19697444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel.
    Gavrilov V; Lifshitz M; Levy J; Gorodischer R
    Isr Med Assoc J; 2000 Aug; 2(8):595-7. PubMed ID: 10979352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unlicensed and off-label drug use in children: implications for safety.
    Choonara I
    Expert Opin Drug Saf; 2004 Mar; 3(2):81-3. PubMed ID: 15006712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sailing the straits of approval: the nature of FDA approval and its implications for surgeons.
    Reiter D
    Facial Plast Surg Clin North Am; 2007 May; 15(2):247-50, vii-viii. PubMed ID: 17544941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Be wary of recommending off-label use of meds.
    Luttrull S
    Adv Nurse Pract; 2001 Feb; 9(2):18. PubMed ID: 12416047
    [No Abstract]   [Full Text] [Related]  

  • 10. Are "off-labels" legal?
    Price EC
    Mich Health Hosp; 1998; 34(6):20-1. PubMed ID: 10187136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off licence and off label prescribing in children: litigation fears for physicians.
    Hill P
    Arch Dis Child; 2005 Feb; 90 Suppl 1(Suppl 1):i17-8. PubMed ID: 15665151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications.
    Kumar P; Walker JK; Hurt KM; Bennett KM; Grosshans N; Fotis MA
    J Pediatr; 2008 Mar; 152(3):412-5. PubMed ID: 18280851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent dosing and labeling since the Food and Drug Administration Amendments Act of 2007.
    Momper JD; Mulugeta Y; Green DJ; Karesh A; Krudys KM; Sachs HC; Yao LP; Burckart GJ
    JAMA Pediatr; 2013 Oct; 167(10):926-32. PubMed ID: 23921678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label medication use in an academic hospital pediatric critical care unit.
    Hsu B; Brazelton T
    WMJ; 2009 Oct; 108(7):343-8. PubMed ID: 19886581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label prescribing. Legal implications.
    Henry V
    J Leg Med; 1999 Sep; 20(3):365-83. PubMed ID: 10530051
    [No Abstract]   [Full Text] [Related]  

  • 16. Food and Drug Administration approval for medications used in the pediatric intensive care unit: a continuing conundrum.
    Yang CP; Veltri MA; Anton B; Yaster M; Berkowitz ID
    Pediatr Crit Care Med; 2011 Sep; 12(5):e195-9. PubMed ID: 21057369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Legal issues in the off-label use of drug medication in in pediatrics].
    Poetsch J
    J Dtsch Dermatol Ges; 2006 May; 4(5):421-6. PubMed ID: 16686611
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.
    Torres A
    Arch Dermatol; 1994 Jan; 130(1):32-6. PubMed ID: 8285737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlicensed and off-label drug use in children.
    Bavdekar SB; Gogtay NJ
    J Postgrad Med; 2005; 51(4):249-52. PubMed ID: 16388164
    [No Abstract]   [Full Text] [Related]  

  • 20. Is the "therapeutic orphan" about to be adopted?
    Coté CJ; Kauffman RE; Troendle GJ; Lambert GH
    Pediatrics; 1996 Jul; 98(1):118-23. PubMed ID: 8668382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.